功能性结肠疾病3种治疗方案的成本-效果分析  

Cost-effectiveness Analysis of Three Therapeutic Schemes for Functional Colonic Diseases

作　　者：田鹤[1] 杨同聚 

机构地区：[1]山东省邹城市人民医院药剂科,邹城市273500

出　　处：《中国医院用药评价与分析》2001年第5期283-284,共2页Evaluation and Analysis of Drug-use in Hospitals of China

摘　　要：目的:探讨不同药物治疗方案对同一疾病所产生的经济效果。方法:根据文献选择148例功能性结肠疾病患者,随机分为3组,分别给予胶体酒石酸铋、双歧杆菌、西沙必利治疗,运用药物经济学的成本-效果分析方法进行评价。结果与结论:胶体酒石酸铋是治疗功能性结肠疾病的较佳药物。OBJECTIVE:To discuss the economical effects of different medications on the treatment of same illness. METHODS: 148 cases of functional colonic diseases were collected from literature and were randomly divided into three groups; colloidal bismuth artrate was given to the first group, bifidobacterium to the second and cisapride to the last. Data was evaluated using the pharmacoeconomic cost-effectiveness analysis. RESULTS: Colloidal bismuth artrate was the best medicine to treat functional colonic diseases. CONCLUSION: The pharmacoeconomics play an important role in guiding the physician to choose the best therapeutic regimen in making clinical decision, so as to gain the maximal benefit with the minimal cost.

关 键 词：功能性结肠疾病 药物治疗 成本-效果分析 胶体酒石酸铋 双歧杆菌 西沙必利 

分 类 号：R574.62[医药卫生—消化系统]